Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.48M Buy
9,898
+1,394
+16% +$497K 0.33% 65
2025
Q4
$2.78M Buy
8,504
+1,793
+27% +$569K 0.27% 70
2025
Q3
$1.89M Buy
6,711
+1
+0% +$290 0.19% 107
2025
Q2
$1.87M Buy
6,710
+386
+6% +$109K 0.2% 106
2025
Q1
$1.97M Buy
6,324
+776
+14% +$229K 0.23% 87
2024
Q4
$1.45M Buy
5,548
+275
+5% +$81.6K 0.16% 130
2024
Q3
$1.7M Buy
5,273
+2,152
+69% +$704K 0.2% 107
2024
Q2
$975K Sell
3,121
-9,324
-75% -$2.74M 0.2% 117
2024
Q1
$3.54M Buy
12,445
+5,217
+72% +$1.53M 0.72% 33
2023
Q4
$2.08M Buy
7,228
+2,271
+46% +$619K 0.36% 29
2023
Q3
$1.33M Buy
+4,957
New +$1.24M 0.44% 44

Other funds holding AMGN

Norden Group's AMGN Position: Q1 2026 in Review

Norden Group increased its Amgen (AMGN) stake by 16% in Q1 2026, buying an estimated $497K and bringing the position to 9,898 shares worth $3.48M. The position accounts for 0.33% of the portfolio, ranked #65.

Norden Group first reported a position in AMGN in Q3 2023 and has held it in 11 quarters since. The position peaked at $3.54M in Q1 2024. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Norden Group held 9,898 shares of Amgen worth $3.48M as of Q1 2026.
  • Norden Group bought 1,394 Amgen shares in Q1 2026, an estimated $497K.
  • Amgen made up 0.33% of Norden Group's portfolio in Q1 2026, its #65 holding.
  • Norden Group first reported a position in Amgen in Q3 2023 and has held it in 11 quarters since.
  • Norden Group's Amgen position peaked at $3.54M in Q1 2024.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Norden Group's 13F filing for Q1 2026, filed 15 Apr 2026.